Moderna, Merck and cancer vaccine
Digest more
Proceeds to be utilized for general corporate purposes which may include the flexibility to invest in the growth of our ...
Robert Langer passed on lucrative oil-industry jobs, endured nine rejected grants, and didn’t co-found Moderna until his 60s.
Prior to the melanoma outcome, indicators included an enrolled trial, a partner covering half the expenses, and a market that ...
CAMBRIDGE, MA / ACCESS Newswire / August 27, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and ...
The biotech firm announced plans to raise $2 billion through convertible notes, which could be increased to $2.3 billion.
Moderna stock is giving back a large chunk of Tuesday’s rally. The pullback reopens a question that a summer melt-up has ...
A personalized vaccine developed by Moderna Inc. and Merck & Co. helped reduce the recurrence of melanoma in a large, ...
21h
BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat
A single trial readout is reshuffling the mRNA vaccine trade this morning. BioNTech SE (NASDAQ:BNTX) stock is down 8% to $102 ...
Moderna just posted an 11% surge with zero news behind it, while its longtime mRNA peer BioNTech can barely keep pace with ...
Shares of Moderna Inc. MRNA are trading lower Friday morning after the company announced official terms for a major private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results